Parvus Therapeutics Inc.
PrivateLast Round
Corporate Funding
Mar 20, 2024
Total Funding Raised
$19.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Parvus Therapeutics Inc. is a clinical-stage biotechnology company developing proprietary pMHC nanomedicine drug candidates designed to trigger the in vivo generation of antigen-specific regulatory T cells (Tregs) to treat autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parvus Therapeutics Inc. Comparables
Compare Parvus Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cour Pharma | 86% | |
| Topas Therapeutics | 84% | |
| Anokion | 83% | |
Parvus Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 20, 2024 | ||||
| Corporate Funding | Apr 19, 2017 | ||||
| Grant | Jul 30, 2009 |
Parvus Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Innovate Calgary | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 80% MoM.
- Jan 19, 2026
Monthly visitors increased 148% MoM, reaching 1.4K.
Parvus Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Parvus Therapeutics Inc.'s valuation, stock price, and market status.